|
Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.
Recent Releases
Nov 19, 2009
BioCryst Announces Pricing of Public Offering of Common Stock
Nov 17, 2009
BioCryst Announces Proposed Public Offering of Common Stock
View all releases »
Investor Relations
Rob Bennett, Executive Director of Business Development & Investor Relations
919.859.7910
investorrelations@biocryst.com
Stockholder Services
Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Co.
59 Maiden Lane
New York, New York 10038
Phone (718) 921-8247
|
